Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS

ClinicalTrials.gov ID: NCT02397057

Public ClinicalTrials.gov record NCT02397057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blinded, Multi-Center, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) in the Treatment of Restless Legs Syndrome (RLS)

Study identification

NCT ID
NCT02397057
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
American Regent, Inc.
Industry
Enrollment
209 participants

Conditions and interventions

Interventions

  • Injectafer Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2014
Primary completion
Dec 31, 2017
Completion
Dec 31, 2017
Last update posted
Oct 11, 2021

2015 – 2018

United States locations

U.S. sites
19
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
Coastal Clinical Research, Inc. Mobile Alabama 36608
Synergy San Diego National City California 91950
Desert Valley Research Rancho Mirage California 92270
Anderson Clinical Research Redlands California 92374
Neurology Offices of South FL Boca Raton Florida 33428
Elite Research Institute Miami Florida 33169
MidAmmerica Neuroscience Institute Lenexa Kansas 66214-1505
Central Kentucky Research Assoc., Inc. Lexington Kentucky 40509
Neuromedical Clinical of Central Louisiana Alexandria Louisiana 71301
Ctr for Brain & Neuro Care, LLC Fulton Maryland 20759
Massachusetts General Hospital, Sleep Disorders Clinical Research Program Boston Massachusetts 02114
Desert Neurology Las Vegas Nevada 89119
Neurology Center of Las Vegas Las Vegas Nevada 89128
Guilford Neurologic Associates Greensboro North Carolina 27405
Metrolina Neurological Associates Old Point Station South Carolina 29707
Saad Upstate Neurology Spartanburg South Carolina 29307
Tri-State Mountain Neurology Associates Johnson City Tennessee 37604
Egret Bay Neurology Houston Texas 77058
The Polyclinic, Madison Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02397057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02397057 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →